Bouriez D, Gronnier C, Haissaguerre M, Tabarin A, Najah H
World J Surg. 2022; 46(11):2666-2675.
PMID: 35767091
DOI: 10.1007/s00268-022-06633-7.
Bjerneroth G, Juhlin C, Grimelius L, Rastad J, Akerstrom G
Endocr Pathol. 2020; 3(2):83-92.
PMID: 32138405
DOI: 10.1007/BF02921347.
Kluijfhout W, Beninato T, Drake F, Vriens M, Gosnell J, Shen W
World J Surg. 2016; 40(12):2964-2969.
PMID: 27402205
PMC: 5104782.
DOI: 10.1007/s00268-016-3624-9.
Iacobone M, Carnaille B, Palazzo F, Vriens M
Langenbecks Arch Surg. 2015; 400(8):867-86.
PMID: 26450137
DOI: 10.1007/s00423-015-1342-7.
Ito T, Igarashi H, Uehara H, Berna M, Jensen R
Medicine (Baltimore). 2013; 92(3):135-181.
PMID: 23645327
PMC: 3727638.
DOI: 10.1097/MD.0b013e3182954af1.
Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.
Twigt B, Scholten A, Valk G, Borel Rinkes I, Vriens M
Orphanet J Rare Dis. 2013; 8:50.
PMID: 23547958
PMC: 3623824.
DOI: 10.1186/1750-1172-8-50.
Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy.
Tonelli F, Giudici F, Cavalli T, Brandi M
Clinics (Sao Paulo). 2012; 67 Suppl 1:155-60.
PMID: 22584722
PMC: 3328832.
DOI: 10.6061/clinics/2012(sup01)26.
Total parathyroidectomy in a large cohort of cases with hyperparathyroidism associated with multiple endocrine neoplasia type 1: experience from a single academic center.
Montenegro F, Lourenco Jr D, Tavares M, Arap S, Nascimento Jr C, Massoni Neto L
Clinics (Sao Paulo). 2012; 67 Suppl 1:131-9.
PMID: 22584718
PMC: 3328834.
DOI: 10.6061/clinics/2012(sup01)22.
The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review.
Schreinemakers J, Pieterman C, Scholten A, Vriens M, Valk G, Borel Rinkes I
World J Surg. 2011; 35(9):1993-2005.
PMID: 21713580
DOI: 10.1007/s00268-011-1068-9.
Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
Pieterman C, Vriens M, Dreijerink K, van der Luijt R, Valk G
Fam Cancer. 2010; 10(1):157-71.
PMID: 21061174
DOI: 10.1007/s10689-010-9398-6.
Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.
Norton J, Venzon D, Berna M, Alexander H, Fraker D, Libutti S
Ann Surg. 2008; 247(3):501-10.
PMID: 18376196
PMC: 2717476.
DOI: 10.1097/SLA.0b013e31815efda5.
[Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism].
Langer P, Wild A, Schilling T, Nies C, Rothmund M, Bartsch D
Chirurg. 2004; 75(9):900-6.
PMID: 15168030
DOI: 10.1007/s00104-004-0838-4.
Multiple endocrine neoplasia type 1 presenting as insulinoma, gastrinoma, and postbulbar duodenal ulcers: report of a case.
Murakami S, Satomi A, Ishida K, Matsuki M, Koda H, Miura S
Surg Today. 1995; 25(9):848-51.
PMID: 8555708
DOI: 10.1007/BF00311466.
Management of primary hyperparathyroidism caused by multiple gland disease.
Goretzki P, Dotzenrath C, Roeher H
World J Surg. 1991; 15(6):693-7.
PMID: 1685044
DOI: 10.1007/BF01665302.
Causes of failed primary exploration and technical aspects of re-operation in primary hyperparathyroidism.
Akerstrom G, Rudberg C, Grimelius L, Johansson H, Lundstrom B, Rastad J
World J Surg. 1992; 16(4):562-8; discussion 568-9.
PMID: 1413826
DOI: 10.1007/BF02067321.
Findings and long-term results of parathyroid surgery in multiple endocrine neoplasia type 1.
Hellman P, Skogseid B, Juhlin C, Akerstrom G, Rastad J
World J Surg. 1992; 16(4):718-22; discussion 722-3.
PMID: 1357833
DOI: 10.1007/BF02067367.
